Cart
sales@molnova.com
Astragaloside II
CAS No. 84676-89-1
Astragaloside II ( Astrasieversianin VIII )
Catalog No. M19174 CAS No. 84676-89-1
Astragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
Purity : 98%
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 72 | In Stock |
|
| 10MG | 115 | In Stock |
|
| 25MG | 194 | In Stock |
|
| 50MG | 286 | In Stock |
|
| 100MG | 422 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameAstragaloside II
-
NoteResearch use only, not for human use.
-
Brief DescriptionAstragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy.
-
DescriptionAstragaloside II is an effective MDR reversal agent and may be a potential adjunctive agent for hepatic cancer chemotherapy. Astragaloside II also induces osteogenic activities, differentiation, proliferation, and mineralization, through the bone morphogenetic protein-2/MAPK and Smad1/5/8 pathways.
-
SynonymsAstrasieversianin VIII
-
PathwayOthers
-
TargetOther Targets
-
RecptorSmad1; Smad5; Smad8
-
Research AreaOthers-Field
-
Indication——
Chemical Information
-
CAS Number84676-89-1
-
Formula Weight798.95
-
Molecular FormulaC41H66O15
-
Purity98%
-
SolubilityDMSO : 100 mg/mL 120.92 mM; H2O : < 0.1 mg/mL
-
SMILESC(=O)(C)O[C@H]1[C@@H](OC[C@H]([C@@H]1O)O)O[C@H]1CC[C@]23C4(CC[C@]5([C@]([C@@H]4C[C@@H]([C@H]2C1(C)C)O[C@H]1[C@@H]([C@H]([C@@H]([C@H](O1)CO)O)O)O)(C[C@@H]([C@@H]5[C@@]1(O[C@@H](CC1)C(C)(C)O)C)O)C)C)C3
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Huang C, et al. Reversal of P-glycoprotein-mediated multidrug resistance of human hepatic cancer cells by Astragaloside II. J Pharm Pharmacol. 2012 Dec;64(12):1741-50.
molnova catalog
related products
-
Hederasaponin B
Hederasaponin B has antiviral activity, via inhibiting the viral VP2 protein expression and blocking viral capsid protein synthesis.
-
Nardosinonediol
Nardosinonediol shows cytotoxic activity against P-388 cells.
-
S961 TFA (1083433-49...
S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 for hir-a, hir-b and human insulin-like growth factor I receptor (higf-ir) at 0.048, 0.027 and 630 nM, respectively.
